We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Agency Sees Benefit in Harmonized for Biosimilars Pathway
Agency Sees Benefit in Harmonized for Biosimilars Pathway
May 7, 2010
While the FDA works to establish an approval pathway for biosimilar products, it needs to take advantage of work already done by foreign regulators, agency officials say.